TMA: beware of complements.

Abstract:

:In this issue of Blood, Jodele and colleagues report that defective complement regulation contributes to the development of thrombotic microangiopathy (TMA) after hematopoietic stem cell transplantation (HSCT) with important implications for diagnosis and management of this severe clinical complication.

journal_name

Blood

journal_title

Blood

authors

Ricklin D,Cines DB

doi

10.1182/blood-2013-07-512707

subject

Has Abstract

pub_date

2013-09-19 00:00:00

pages

1997-9

issue

12

eissn

0006-4971

issn

1528-0020

pii

122/12/1997

journal_volume

122

pub_type

评论,杂志文章

相关文献

BLOOD文献大全
  • Activation of the mitogen-activated protein kinase pathway is involved in and sufficient for megakaryocytic differentiation of CMK cells.

    abstract::Activation of the mitogen-activated protein (MAP) kinase pathway has been associated with both cell proliferation and differentiation. Constitutively activated forms of Mek (MAP kinase/Erk kinase) and Erk (MAP kinase) have been previously shown capable of inducing differentiation or proliferation in nonhematopoietic c...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Melemed AS,Ryder JW,Vik TA

    更新日期:1997-11-01 00:00:00

  • AML with 11q23/MLL abnormalities as defined by the WHO classification: incidence, partner chromosomes, FAB subtype, age distribution, and prognostic impact in an unselected series of 1897 cytogenetically analyzed AML cases.

    abstract::Acute myeloid leukemia (AML) cases with 11q23 abnormalities involving the MLL gene comprise one category of recurring genetic abnormalities in the WHO classification. In an unselected series of 1897 AML cases, 54 patients with an 11q23/MLL rearrangement were identified, resulting in an incidence of 2.8%. The incidence...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-02-0434

    authors: Schoch C,Schnittger S,Klaus M,Kern W,Hiddemann W,Haferlach T

    更新日期:2003-10-01 00:00:00

  • IGF-1 suppresses Bim expression in multiple myeloma via epigenetic and posttranslational mechanisms.

    abstract::Insulin-like growth factor-1 (IGF-1) is an important growth and survival factor in multiple myeloma (MM). Here, we demonstrate that IGF-1 induces significant down-regulation of the proapoptotic BH3-only protein Bim in MM cells. Reduced Bim levels by RNA interference (RNAi) protected cells from drug-induced cell death....

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-07-232801

    authors: De Bruyne E,Bos TJ,Schuit F,Van Valckenborgh E,Menu E,Thorrez L,Atadja P,Jernberg-Wiklund H,Vanderkerken K

    更新日期:2010-03-25 00:00:00

  • Hematopoietic stem cell transplantation for infantile osteopetrosis.

    abstract::We report the international experience in outcomes after related and unrelated hematopoietic transplantation for infantile osteopetrosis in 193 patients. Thirty-four percent of transplants used grafts from HLA-matched siblings, 13% from HLA-mismatched relatives, 12% from HLA-matched, and 41% from HLA-mismatched unrela...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2015-01-625541

    authors: Orchard PJ,Fasth AL,Le Rademacher J,He W,Boelens JJ,Horwitz EM,Al-Seraihy A,Ayas M,Bonfim CM,Boulad F,Lund T,Buchbinder DK,Kapoor N,O'Brien TA,Perez MA,Veys PA,Eapen M

    更新日期:2015-07-09 00:00:00

  • Metnase mediates chromosome decatenation in acute leukemia cells.

    abstract::After DNA replication, sister chromatids must be untangled, or decatenated, before mitosis so that chromatids do not tear during anaphase. Topoisomerase IIalpha (Topo IIalpha) is the major decatenating enzyme. Topo IIalpha inhibitors prevent decatenation, causing cells to arrest during mitosis. Here we report that acu...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-08-175760

    authors: Wray J,Williamson EA,Sheema S,Lee SH,Libby E,Willman CL,Nickoloff JA,Hromas R

    更新日期:2009-08-27 00:00:00

  • Acute onset hemoglobinemia and/or hemoglobinuria and sequelae following Rh(o)(D) immune globulin intravenous administration in immune thrombocytopenic purpura patients.

    abstract::Rh(o)(D) immune globulin intravenous (anti-D IGIV) was licensed by the United States Food and Drug Administration (FDA) in March 1995 to treat patients with immune thrombocytopenic purpura (ITP). Anti-D IGIV induces extravascular hemolysis, an expected adverse reaction that is consistent with the presumed mechanism of...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:

    authors: Gaines AR

    更新日期:2000-04-15 00:00:00

  • Selection of patients for bone marrow transplantation in severe aplastic anemia.

    abstract::Despite androgens and intensive supportive care, satisfactory survival in severe aplastic anemia remains at 20% or less. Histocompatible bone marrow transplantation can restore normal hematopoiesis in approximately 40% of similarly severe individuals. Delay of transplantation for 3 wk after diagnosis allows time for p...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Camitta BM,Rappeport JM,Parkman R,Nathan DG

    更新日期:1975-03-01 00:00:00

  • Merkel cell polyomavirus DNA sequences in the buffy coats of healthy blood donors.

    abstract::Merkel cell polyomavirus (MCPyV), a DNA tumor virus, has been found to be associated with Merkel cell carcinoma and chronic lymphocytic leukemia. MCPyV sequences have also been detected in various normal tissues in tumor-affected patients. Immunologic studies have detected MCPyV antibodies in as many as 80% of healthy...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-09-310557

    authors: Pancaldi C,Corazzari V,Maniero S,Mazzoni E,Comar M,Martini F,Tognon M

    更新日期:2011-06-30 00:00:00

  • Allele-specific DNA methylation reinforces PEAR1 enhancer activity.

    abstract::Genetic variation in the PEAR1 locus is linked to platelet reactivity and cardiovascular disease. The major G allele of rs12041331, an intronic cytosine guanine dinucleotide-single-nucleotide polymorphism (CpG-SNP), is associated with higher PEAR1 expression in platelets and endothelial cells than the minor A allele. ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2015-11-682153

    authors: Izzi B,Pistoni M,Cludts K,Akkor P,Lambrechts D,Verfaillie C,Verhamme P,Freson K,Hoylaerts MF

    更新日期:2016-08-18 00:00:00

  • "You break it, you fix it.".

    abstract::Nonrandom chromosomal translocations are considered to be causal events leading to leukemic transformation. However, the mechanism(s) that cause these translocations are poorly understood. Libura and colleagues report exciting new findings on the mechanism(s) that lead to chromosomal translocation. ...

    journal_title:Blood

    pub_type: 评论,杂志文章,评审

    doi:10.1182/blood-2004-12-4760

    authors: Aplan PD

    更新日期:2005-03-01 00:00:00

  • Recombinant toxins containing human granulocyte-macrophage colony-stimulating factor and either pseudomonas exotoxin or diphtheria toxin kill gastrointestinal cancer and leukemia cells.

    abstract::The granulocyte-macrophage colony-stimulating factor receptor (GM-CSFR) is a potential target for toxin-directed therapy, because it is overexpressed on many leukemias and solid tumors and apparently not on stem cells. To investigate the potential therapeutic use of GM-CSF toxins, we fused human GM-CSF to truncated fo...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Kreitman RJ,Pastan I

    更新日期:1997-07-01 00:00:00

  • A mutation in the Gardos channel is associated with hereditary xerocytosis.

    abstract::The Gardos channel is a Ca(2+)-sensitive, intermediate conductance, potassium selective channel expressed in several tissues including erythrocytes and pancreas. In normal erythrocytes, it is involved in cell volume modification. Here, we report the identification of a dominantly inherited mutation in the Gardos chann...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2015-04-642496

    authors: Rapetti-Mauss R,Lacoste C,Picard V,Guitton C,Lombard E,Loosveld M,Nivaggioni V,Dasilva N,Salgado D,Desvignes JP,Béroud C,Viout P,Bernard M,Soriani O,Vinti H,Lacroze V,Feneant-Thibault M,Thuret I,Guizouarn H,Badens C

    更新日期:2015-09-10 00:00:00

  • Protein S enhances C4b binding protein interaction with neutrophils.

    abstract::Protein S, an inhibitor of coagulation, interacts reversibly with C4b binding protein (C4bBP). The physiologic role of this complex formation remains unknown. In this study we examined the possibility that protein S would facilitate C4bBP binding to the surface of neutrophils where, in turn, this complex could help pr...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Furmaniak-Kazmierczak E,Hu CY,Esmon CT

    更新日期:1993-01-15 00:00:00

  • A novel mutation in the coding sequence of the FY*B allele of the Duffy chemokine receptor gene is associated with an altered erythrocyte phenotype.

    abstract::The Duffy blood group system is of clinical and biological significance. Antibodies to Duffy antigens are responsible for some cases of transfusion incompatibility and newborn hemolytic disease. The Duffy protein is a receptor for the Plasmodium vivax erythrocyte-binding protein and is also a receptor for various chem...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Parasol N,Reid M,Rios M,Castilho L,Harari I,Kosower NS

    更新日期:1998-10-01 00:00:00

  • Proteomics-based discovery of a novel, structurally unique, and developmentally regulated plasminogen receptor, Plg-RKT, a major regulator of cell surface plasminogen activation.

    abstract::Activation of plasminogen, the zymogen of the primary thrombolytic enzyme, plasmin, is markedly promoted when plasminogen is bound to cell surfaces, arming cells with the broad spectrum proteolytic activity of plasmin. In addition to its role in thrombolysis, cell surface plasmin facilitates a wide array of physiologi...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-11-188938

    authors: Andronicos NM,Chen EI,Baik N,Bai H,Parmer CM,Kiosses WB,Kamps MP,Yates JR 3rd,Parmer RJ,Miles LA

    更新日期:2010-02-18 00:00:00

  • HHEX promotes myeloid transformation in cooperation with mutant ASXL1.

    abstract::Additional sex combs-like 1 (ASXL1), an epigenetic modulator, is frequently mutated in myeloid neoplasms. Recent analyses of mutant ASXL1 conditional knockin (ASXL1-MT-KI) mice suggested that ASXL1-MT alone is insufficient for myeloid transformation. In our previous study, we used retrovirus-mediated insertional mutag...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2019004613

    authors: Takeda R,Asada S,Park SJ,Yokoyama A,Becker HJ,Kanai A,Visconte V,Hershberger C,Hayashi Y,Yonezawa T,Tamura M,Fukushima T,Tanaka Y,Fukuyama T,Matsumoto A,Yamasaki S,Nakai K,Yamazaki S,Inaba T,Shibata T,Inoue D,Ho

    更新日期:2020-10-01 00:00:00

  • Enhanced engraftment of hematopoietic progenitor cells in mice treated with granulocyte colony-stimulating factor before low-dose irradiation: implications for gene therapy.

    abstract::Gene therapy for inherited disorders of blood cells will require both efficient methods for stable gene transfer and nonablative bone marrow conditioning regimens to allow engraftment of modified hematopoietic progenitor cells (HPCs). We have used a sensitive murine system for detecting HPC engraftment using congenic ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Mardiney M 3rd,Malech HL

    更新日期:1996-05-15 00:00:00

  • Missing KIR ligands are associated with less relapse and increased graft-versus-host disease (GVHD) following unrelated donor allogeneic HCT.

    abstract::Natural killer (NK) cells can alter the outcome of hematopoietic cell transplantation (HCT) if donor alloreactivity targets the recipient. Since most NK cells express inhibitory killer-immunoglobulin receptors (KIRs), we hypothesized that the susceptibility of recipient cells to donor NK cell-mediated lysis is genetic...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2007-01-065383

    authors: Miller JS,Cooley S,Parham P,Farag SS,Verneris MR,McQueen KL,Guethlein LA,Trachtenberg EA,Haagenson M,Horowitz MM,Klein JP,Weisdorf DJ

    更新日期:2007-06-01 00:00:00

  • Splice site mutations are a common cause of X-linked chronic granulomatous disease.

    abstract::Chronic granulomatous disease (CGD) is characterized by the absence of a respiratory burst in activated phagocytes. Defects in at least four different genes lead to CGD. Patients with the X-linked form of CGD have mutations in the gene for the beta-subunit of cytochrome b558 (gp91-phox). We studied the molecular defec...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: de Boer M,Bolscher BG,Dinauer MC,Orkin SH,Smith CI,Ahlin A,Weening RS,Roos D

    更新日期:1992-09-15 00:00:00

  • Reduced frequencies and suppressive function of CD4+CD25hi regulatory T cells in patients with chronic lymphocytic leukemia after therapy with fludarabine.

    abstract::Globally suppressed T-cell function has been described in many patients with cancer to be a major hurdle for the development of clinically efficient cancer immunotherapy. Inhibition of antitumor immune responses has been mainly linked to inhibitory factors present in cancer patients. More recently, increased frequenci...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2005-02-0642

    authors: Beyer M,Kochanek M,Darabi K,Popov A,Jensen M,Endl E,Knolle PA,Thomas RK,von Bergwelt-Baildon M,Debey S,Hallek M,Schultze JL

    更新日期:2005-09-15 00:00:00

  • Regulation of B-cell development by BCAP and CD19 through their binding to phosphoinositide 3-kinase.

    abstract::Despite the importance of phosphoinositide 3-kinase (PI3K) in B-cell development, its activation mechanism still remains elusive. In this study, we show that deletion of both BCAP and CD19 leads to an almost complete block of BCR-mediated Akt activation and to severe defects in generation of immature and mature B cell...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2007-08-109769

    authors: Aiba Y,Kameyama M,Yamazaki T,Tedder TF,Kurosaki T

    更新日期:2008-02-01 00:00:00

  • Substrate for endothelial prostacyclin production in the presence of platelets exposed to collagen is derived from the platelets rather than the endothelium.

    abstract::Interactions between vascular endothelial cells and blood platelets have been investigated using a model microcirculation consisting of microcarrier beads colonized with human umbilical vein endothelial cells (HUVECs) and perfused with washed platelet suspensions. To simulate the effects of endothelial desquamation an...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Chesterman CN,Owe-Young R,Macpherson J,Krilis SA

    更新日期:1986-06-01 00:00:00

  • Cyclosporin-A is selectively cytotoxic to human leukemic T cells in vitro.

    abstract::We have studied the antileukemic effects of cyclosporin-A (CyA) on the cells of a number of human hematopoietic biopsies and established cell lines in vitro. Cya killed the tumor cells but not the nonmalignant control cells from three of four patients with T-lymphocytic leukemia/lymphoma at concentrations comparable t...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Tötterman TH,Danersund A,Nilsson K,Killander A

    更新日期:1982-05-01 00:00:00

  • Insulin-like growth factor 2 expressed in a novel fetal liver cell population is a growth factor for hematopoietic stem cells.

    abstract::Hematopoietic stem cells (HSCs) undergo dramatic expansion during fetal liver development, but attempts to expand their numbers ex vivo have failed. We hypothesized that unidentified fetal liver cells produce growth factors that support HSC proliferation. Here we describe a novel population of CD3+ and Ter119- day-15 ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-08-2955

    authors: Zhang CC,Lodish HF

    更新日期:2004-04-01 00:00:00

  • Loss of MHC class II gene and protein expression in diffuse large B-cell lymphoma is related to decreased tumor immunosurveillance and poor patient survival regardless of other prognostic factors: a follow-up study from the Leukemia and Lymphoma Molecular

    abstract::The Leukemia and Lymphoma Molecular Profiling Project recently published results from DNA microarray analyses of 240 diffuse large B-cell lymphomas (DLBCLs). Four gene expression "signatures" were identified as correlated with patient outcome, including the major histocompatibility complex (MHC) class II genes (eg, HL...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-07-2365

    authors: Rimsza LM,Roberts RA,Miller TP,Unger JM,LeBlanc M,Braziel RM,Weisenberger DD,Chan WC,Muller-Hermelink HK,Jaffe ES,Gascoyne RD,Campo E,Fuchs DA,Spier CM,Fisher RI,Delabie J,Rosenwald A,Staudt LM,Grogan TM

    更新日期:2004-06-01 00:00:00

  • Clonal regulatory T cells specific for a red blood cell autoantigen in human autoimmune hemolytic anemia.

    abstract::Regulatory T (Tr) cells have the potential to treat immune-mediated disease, but cloning such cells for study from patients with autoimmune disease has proven difficult. Here, we describe autoantigen-specific, interleukin-10 (IL-10)-secreting Tr cell clones recovered ex vivo from a patient with autoimmune hemolytic an...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2007-07-101345

    authors: Ward FJ,Hall AM,Cairns LS,Leggat AS,Urbaniak SJ,Vickers MA,Barker RN

    更新日期:2008-01-15 00:00:00

  • Serum ferritin as risk factor for sinusoidal obstruction syndrome of the liver in patients undergoing hematopoietic stem cell transplantation.

    abstract::Hepatic sinusoidal obstruction syndrome (SOS) is a serious complication in hematopoietic stem cell transplant (HSCT) recipients. To determine the impact of pretransplantation hyperferritinemia on the risk of SOS after HSC transplantation, we retrospectively studied 427 HSCT recipients (179 autologous and 248 allogenei...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-03-212282

    authors: Maradei SC,Maiolino A,de Azevedo AM,Colares M,Bouzas LF,Nucci M

    更新日期:2009-08-06 00:00:00

  • Enhanced normal short-term human myelopoiesis in mice engineered to express human-specific myeloid growth factors.

    abstract:UNLABELLED:Better methods to characterize normal human hematopoietic cells with short-term repopulating activity cells (STRCs) are needed to facilitate improving recovery rates in transplanted patients.We now show that 5-fold more human myeloid cells are produced in sublethally irradiated NOD/SCID-IL-2Receptor-γchain-n...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2012-09-456566

    authors: Miller PH,Cheung AM,Beer PA,Knapp DJ,Dhillon K,Rabu G,Rostamirad S,Humphries RK,Eaves CJ

    更新日期:2013-01-31 00:00:00

  • Leveraging increased cytoplasmic nucleoside kinase activity to target mtDNA and oxidative phosphorylation in AML.

    abstract::Mitochondrial DNA (mtDNA) biosynthesis requires replication factors and adequate nucleotide pools from the mitochondria and cytoplasm. We performed gene expression profiling analysis of 542 human acute myeloid leukemia (AML) samples and identified 55% with upregulated mtDNA biosynthesis pathway expression compared wit...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2016-10-741207

    authors: Liyanage SU,Hurren R,Voisin V,Bridon G,Wang X,Xu C,MacLean N,Siriwardena TP,Gronda M,Yehudai D,Sriskanthadevan S,Avizonis D,Shamas-Din A,Minden MD,Bader GD,Laposa R,Schimmer AD

    更新日期:2017-05-11 00:00:00

  • Eliglustat maintains long-term clinical stability in patients with Gaucher disease type 1 stabilized on enzyme therapy.

    abstract::In the phase 3 Study of Eliglustat Tartrate (Genz-112638) in Patients With Gaucher Disease Who Have Reached Therapeutic Goals With Enzyme Replacement Therapy (ENCORE), at 1 year, eliglustat was noninferior to imiglucerase enzyme therapy in maintaining stable platelet counts, hemoglobin concentrations, and spleen and l...

    journal_title:Blood

    pub_type: 杂志文章,随机对照试验

    doi:10.1182/blood-2016-12-758409

    authors: Cox TM,Drelichman G,Cravo R,Balwani M,Burrow TA,Martins AM,Lukina E,Rosenbloom B,Goker-Alpan O,Watman N,El-Beshlawy A,Kishnani PS,Pedroso ML,Gaemers SJM,Tayag R,Peterschmitt MJ

    更新日期:2017-04-27 00:00:00